Business

November 19, 2013

Horizon Pharma acquires U.S. rights to Pozen drug Vimovo

Pozen announced Tuesday that Horizon Pharma USA will acquire U.S. rights to Vimovo, an arthritis pain reliever, from AstraZeneca.

Related content

Comments

Editor's Choice Videos